
Lowercase Capital
200 Townsend Street, San Francisco, California, 94107, United States
Overview
Lowercase Capital is a private equity and venture capital firm specializing in investments in seed/startups, mature, and acquisition of later-stage companies. The firm typically invests in wireless, media, commerce, infrastructure, energy, and transportation sectors. It also advises businesses and funds. Lowercase Capital was founded in 2010 and is based in New York, New York.
- Total investments
- 99
- Lead investments
- 4
- Investments · 12mo
- 1
- Active investors
- 3
Sector focus
- Finance
- Financial Services
- Venture Capital
Investment portfolio
- MiSalud
Participated · Equity · Nov 2025
MiSalud Health offers a bilingual healthcare platform that combines an open-sourced large language model with culturally competent physicians and health coaches to automate administrative tasks, improve health literacy, and deliver personalized care. The service reaches employees in agriculture, construction, manufacturing, and hospitality through job-site events and virtual consultations, making quality care more accessible and affordable for underserved communities. MiSalud’s AI assists clinicians by streamlining workflows, thereby lowering costs and enhancing patient engagement. The company currently serves over 100,000 members across North America. With its latest capital infusion, MiSalud plans to expand operations into 20 additional U.S. states and roll out services that traditionally require in-person visits. Including the newest financing, MiSalud has raised a total of $18.3 million from venture investors.
- Stensul
Participated · Series C · Nov 2023
Stensul is a multi-channel marketing creation platform that began focused on email and provides tools to help customers create campaigns more easily. This year it expanded beyond email with a no-code, drag-and-drop Landing Page builder, generative AI tools to speed content creation, and email localization for multi-language campaigns. CEO Noah Dinkin emphasizes email as a high-ROI channel benefiting from better data and personalization capabilities. The company reports growth among enterprise and mid-market segments and says it is on track for its largest quarter in the company’s history in Q4. Stensul plans to use new capital to increase investment in product development, including AI capabilities launched earlier this year, and to add go-to-market resources to accelerate enterprise adoption. Stensul builds software to streamline the process of creating marketing emails, aiming to reduce a task that can take weeks down to about two hours. The platform includes built-in brand guidelines, workflow for feedback and approval, and integrations such as Workfront to connect with work management. It positions itself as focused on email creation rather than delivery, arguing that large marketing clouds do not center on builders. The team recently grew to more than 100 employees, and the company says over half its staff are engineers dedicated to email creation. Customers include Capital One, ASICS Digital, Greenhouse, Samsung, AppDynamics, Kroger and Clover Health. Stensul raised $16M in a Series B to fund expansion of its marketing, product, engineering and sales teams. Stensul focuses exclusively on the email creation process, enabling marketers at large enterprises to build emails themselves in less than 20 minutes without coding or Photoshop. The platform enforces brand governance and rules and guarantees technically correct output. Stensul integrates with email service providers rather than competing with them, including Salesforce Marketing Cloud, Oracle Marketing Cloud, Adobe Marketing Cloud and Marketo. The company spun out of CEO Noah Dinkin’s previous company FanBridge. Customers include YouTube, Grubhub, BMW, Lyft and Box. With the new funding, Stensul plans to continue investing in product while growing sales and marketing.
- Tala
Participated · Series E · Oct 2021
Tala builds vertically integrated financial infrastructure powered by a proprietary data warehouse to deliver accessible financial services. The company has delivered more than US$6 billion in credit to over 10 million customers across Latin America, Southeast Asia and East Africa. Led by CEO and Founder Shivani Siroya, Tala provides products that help customers start and expand small businesses, manage day-to-day needs, and pursue financial goals. The company raised a US$150M debt facility with Neuberger Berman and plans to use the funds to accelerate its reach, innovate further, and deepen impact in markets like Mexico and beyond. Tala has previously raised nearly half a billion dollars in equity and debt from investors including Upstart, IVP, Revolution Growth, Kindred Ventures, Lowercase Capital and PayPal Ventures. Tala offers mobile, collateral-free loans ranging from $10 to $500 and uses users’ phone data and activity to build credit scores. The company launched its Android app in 2014 and now serves customers in Kenya, the Philippines, Mexico and India. More than 6 million customers use Tala and it has disbursed over $2.7 billion in credit; roughly 12,000 new users sign up daily. Tala says it is transitioning from a credit product to a broader financial account offering — enabling customers to borrow, save, manage, protect and grow money. The PayPal-backed company plans to build mass-market crypto and blockchain-enabled products to support its capital markets strategy and connect investors and borrowers. With the new capital Tala will grow its team across its four markets and the U.S., and accelerate unspecified plans for further geographic expansion. Tala uses an Android app and machine learning to build credit profiles from users' texts, call logs, merchant transactions and app behavior, then issues instant, uncollateralized loans typically between $10 and $500. Its algorithms evaluate individual risk and Tala approves and disburses loans within minutes via mobile payment platforms. To date the company has lent over $1 billion to more than 4 million customers (up from $300 million to 1.3 million customers last year) and employs more than 550 people; it charges a one-time fee as low as 5% per loan. Tala forwards positive credit history to local credit bureaus and reports that more than 90% of users repay within 20–30 days, driving repeat usage. The startup will use new capital to enter India after a 12-month pilot, has set up a technology hub in Bangalore, and plans to expand teams and products in its existing markets. It is also eyeing additional countries in South Asia and Latin America. Tala provides financial services for underserved consumers using their mobile phones. The company is based in Santa Monica and is led by CEO Shivani Siroya. Tala disclosed it has received new funding from PayPal. The size of the new funding was not announced in the article. Tala previously raised funding from Revolution Growth, IVP, Data Collective, Lowercase Capital and Ribb. No financial metrics or product specifics beyond mobile-based financial services were provided in the article. Tala has built a smartphone app that provides instant credit scoring, lending, and personalized financial services in emerging markets using proprietary machine‑learning credit scoring that analyzes alternative data from customers' mobile devices. Its models process signals such as texts and calls, merchant transactions, app usage, and personal identifiers to extend credit to people with little or no formal financial history. Tala issues unsecured loans ranging from $10 to $500 USD and disburses funds to mobile wallets or other payment rails chosen by customers. The company launched Kenya’s first smartphone‑based lending app in 2014 and has since expanded to Tanzania, the Philippines, Mexico and plans to bring its consumer lending app to India. Through its platform Tala has delivered more than 6 million loans to nearly 1.3 million customers and has originated over $300 million globally. The company maintains offices in Santa Monica, Nairobi, Manila, Dar Es Salaam, Mexico City, Mumbai, and Bangalore.
- Pachama
Participated · Equity · Jan 2020
Pachama develops technology that harnesses satellite data and AI to deliver insights on how forests sequester carbon, protect wildlife, and support local livelihoods. The company provides tools that help companies identify and invest in high-quality reforestation and conservation projects and helps land stewards estimate carbon, start projects, and secure funding. Pachama has evaluated projects worldwide and developed Pachama Original projects in Brazil, Mexico, and the United States, and has served clients such as Salesforce, Nespresso, Shopify, and Boston Consulting Group. In Q3 2023 the company reported 57% year‑over‑year growth in credits retired, underscoring increased demand for its rigorously vetted projects. The additional capital announced in the extension will fund R&D in AI applied to geospatial data and expand products and services for companies and project developers. Pachama also announced board appointment of Ebony Beckwith as an independent board member as it scales its nature-based climate solutions. Pachama is a San Francisco-based technology company that leverages satellite imagery, remote sensing and machine learning to measure the carbon stored in forests and monitor forest growth over time. Through its platform, responsible companies can confidently invest in high-quality forest conservation projects verified by Pachama’s evaluation process. The company says it has worked with 46 forest project developers in 14 countries, reviewed over 150 forest projects globally and counts more than 800 sustainably-minded organizations as customers, including Salesforce, Microsoft, Nespresso, Airbnb, Netflix, Softbank, Vuori, and Flexport. Pachama intends to use the Series B proceeds to continue building a scientifically rigorous, technology-based approach to forest carbon credit verification, acquire talent, expand efforts to reach corporate and forest developers, accelerate R&D, and scale the technology needed to transform carbon markets. Diego Saez Gil is CEO and co-founder and the company is based in San Francisco, CA. The new round brings Pachama’s total investment secured to $79M. Pachama operates a verified marketplace for forest carbon credits that combines satellite imagery and machine learning to improve transparency and verifiability. The company says its technology enables validation, monitoring and measurement of forest projects to support corporate carbon-offset purchases. Pachama launched in 2020 and has attracted paying customers including Mercado Libre, Microsoft, Shopify and SoftBank, and received a public shout-out from Jeff Bezos. The startup has recruited talent from companies such as Google, Facebook, SpaceX, Tesla, OpenAI, Microsoft, Impossible Foods and Orbital Insights. Pachama plans to use new funding for product development and continued expansion of its marketplace. Financially, the company raised $15 million in its latest financing and has amassed nearly $24 million in capital since its 2020 launch. Pachama provides remote verification and monitoring of forestry offset projects using satellite imagery and AI to measure carbon captured by forests. The company offers enterprise tools to onboard and monitor carbon removal projects, creating new levels of measurement, monitoring, and verification. Pachama said it will scale its forest restoration and conservation emissions‑reduction monitoring service. To support that effort it raised $5 million in fresh funding, bringing total capital raised to $9 million. The product is positioned as timely amid Western US wildfires and ongoing deforestation globally. Founder Diego Saez‑Gil lost his home in the California wildfires earlier this year, and investors cited growing corporate demand from businesses with ESG commitments. Pachama builds a marketplace to connect verified reforestation projects with buyers of carbon offsets and provides monitoring and management services using satellite imagery and sensors. The company verifies projects approved by existing certification bodies and seeks to bring trust and independent validation to carbon markets. Founder Diego Saez-Gil launched the effort after observing deforestation impacts firsthand and the company currently lists 23 forest projects in Brazil, Peru and multiple U.S. states (California, Vermont, New Jersey, Connecticut and Maine). Pachama raised $4.1 million from a consortium of investors to create the marketplace and its monitoring software. Its business becomes profitable only if carbon prices exceed about $15 per ton; today only California and European markets have reached that level. The team sees regulatory demand (for example CORSIA for airlines) as a potential driver of future offset demand and plans to scale listings and verification to meet that demand.
- Nurx
Participated · Debt Financing · Aug 2019
Nurx operates a digital healthcare platform that connects patients, medical providers, and pharmacies in a single “all in one” service for sensitive health needs. The company focuses on areas that can be difficult to access and carry stigma, including contraception, HIV prevention with PrEP, STI testing and treatment, and herpes treatment. Nurx is available to roughly 90% of the U.S. population and provides care to more than 300,000 patients on a monthly basis. Led by CEO Varsha Rao, the company plans to use new capital to drive patient growth and introduce additional sensitive health services, including treatment for headaches and migraines. Nurx also intends to expand its clinical, operations, and engineering teams in the near future. Financially, the company has raised $113m to date, including the latest Series C tranche. Nurx ships birth control (pill, shot, ring, patch) directly to consumers and also provides emergency contraception, STI and HPV testing kits, and PrEP. The company reports about 200,000 current patients and monthly growth rates as high as 20%. Its service is live in 26 states and Washington, D.C., and Nurx says it plans to be accessible to 90% of the U.S. population by the end of the year. Nurx added STI testing kits last month and has performed tests for 1,000 patients. The company raised $32 million in Series C equity and secured $20 million in debt financing (total new capital $52 million) and has raised more than $90 million in debt and equity to date. Nurx plans to use the funding to double its engineering team and to launch additional "sensitive" healthcare services. Nurx launched in 2014 as a California-based telemedicine startup aiming to make access to contraceptives simple through an online app that connects users with physicians, issues prescriptions, and arranges delivery. The company operates in 17 states and has expanded its product set beyond contraceptive pills to include patches, injectables, the NuvaRing and the anti-HIV medication PrEP. Nurx is preparing to launch an at-home lab kit for HIV testing to further broaden its telehealth offerings. With current plans to scale clinical teams, partner pharmacies, and geographic reach, the company is also building out engineering and design teams and onboarding nurses at a new Miami site. CEO and co-founder Hans Gangeskar frames affordable access to birth control as a foundational health-care function and a starting point for changing how patients receive medications. Nurx operates a web app where users submit information, which is sent to a network of doctors who write prescriptions that Nurx readies for home delivery. The core product is on-demand delivery of contraceptives; the company also offers alternatives such as the NuvaRing and the patch. Nurx expanded its services earlier in the year to include delivery of PrEP (an anti-HIV medication) and has a partnership with LabCorp to help patients get test results and streamline delivery of needed HIV drugs. The startup launched in 2014 to address urgent prescription gaps and has been growing at a steady pace according to its founders. The company faces potential demand-side headwinds noted in the article—citing a new study linking the pill to depression—but continues to broaden its prescription offerings. Its model emphasizes convenience and recurring monthly prescriptions as a pathway for expansion into other medications.